11 Oversold Global Stocks to Buy According to Hedge Funds

6. Avantor, Inc. (NYSE:AVTR)

RSI: 28.75

Number of Hedge Fund Holders: 39

​​Avantor, Inc. (NYSE:AVTR) is a provider of mission-critical products and services for the life sciences, advanced technologies, and applied materials industries. The company’s Laboratory Solutions and Bioscience Production segments offer ultra-high-purity chemicals, laboratory supplies, equipment, and services for daily operations. AVTR is a truly global player that leverages its presence in 180+ countries and vertical integration to get ahead of the competition.

Avantor, Inc. (NYSE:AVTR) faced challenges in Q1 2025, with organic revenue declining 2% YoY, primarily due to underperformance in the Lab business. The company’s performance was impacted by funding uncertainty in the US higher education system, weak funding for bench-stage biotech companies, and increased competitive intensity. Despite these headwinds, AVTR delivered earnings and margin in line with its plan, with adjusted EBITDA margin increasing by 20 basis points YoY to reach 17%, which makes it one of the oversold stocks to consider now.

In response to these challenges, Avantor, Inc. (NYSE:AVTR) is taking decisive actions to enhance growth and strengthen the business. The company is implementing immediate and significant changes in the Lab Solutions segment, including aggressive pursuit of new accounts and retention of key accounts. AVTR is also accelerating digital enhancements, optimizing pricing strategies, and expanding its product portfolio. Additionally, the company has expanded its cost transformation initiative, now targeting approximately $400 million in run-rate gross savings by the end of 2027, up from the previous target of $300 million.